××Ļ×××Ē ×׊ר×Ē ××××ק ×××ר××Ē ××××××Ē ××××Ēר ××ĸ××× ×× ××××Ē× ×§×× ×××Ēר
×ר×׊×× Medical Science Liaison Msl - Oncology South ×-Msd ×-×××××
××Ļ×× ××Ē ×××Ē××× ×××׊×××Ē ×ĸ××ר×× ×ĸ× ×קץפ××× ×! ××¤×Š× ××××× ××××Ē ×ĸ×××× ××Ē×ר Medical Science Liaison Msl - Oncology South ×-Italy ×××Ļ××¨×¤× ×ר׊×Ē ×××ר××Ē ××××××××Ē ××Ē×ĸ׊×××Ē ×××××ק, ××× Msd. ××ר׊×× ×ĸ×׊×× ×××Ļ×× ××Ē ×ĸ××××Ē ×××××××Ē ׊×× ×ĸ× ×קץפ××× ×!
×××¨× (1)
×××¤× ××׊ר×
ק×××ר×××Ē ×Ēפק××
×Š× ×Ēפק×× (1)
Italy
×ĸ×ר
× ××Ļ×× 2 ×׊ר××Ē
21.07.2024
MSD
MSD Medical Science Liaison MSL - Oncology South Italy, Lazio
×Ē×××ר:פר×× ×××Š×¨× ××××××
Engaging in non-promotional peer-to-peer exchange of medical and scientific information with SLs or KDMs to the extent permitted by law and local regulation, local industry codes, and other provisions of...
×׊ר××Ē × ×ץפ××Ē ׊××××××Ē ××ĸ× ××× ×××Ē×
06.07.2024
MSD
MSD New Products Oncology Director Italy, Lazio
×Ē×××ר:פר×× ×××Š×¨× ××××××
Assessing the market potential of pipeline assets and evaluate their commercial viability, taking into account market dynamics, competitive intelligence, scientific insights, regulatory and market access requirements, in line with our...
×Ē×××ר:פר×× ×××Š×¨× ××××××
Engaging in non-promotional peer-to-peer exchange of medical and scientific information with SLs or KDMs to the extent permitted by law and local regulation, local industry codes, and other provisions of...
×׊ר××Ē × ×ץפ××Ē ׊××××××Ē ××ĸ× ××× ×××Ē×
×××× ×××Ļ×× ××Ē ×ĸ××××Ē ×××××××Ē ׊××× ×××××ק ×ĸ× ×קץפ××× ×. ××××Ļ×ĸ××Ē ×פ××פ×ר×× ×Š×× × ×Ē××× ××פ׊ ×ק×××Ē ××××× ××××Ē Medical Science Liaison Msl - Oncology South ×××ר×Ē Msd ×-Italy. ××× ×× ××Ē× ××פ׊×× ××Ē×ר ××׊ ×××× ×× ××Ē× ×¨××Ļ×× ××ĸ××× ×ĸ× ×ר××× ×Ą×¤×Ļ××¤× ××Ēפק×× ×ץ×××, Expoint ×ק×× ×ĸ× ××Ļ×××Ē ××Ē×××Ē ××ĸ×××× ×××׊×××Ē ×ĸ××ר××. ××Ē×××¨× ×××ר××Ē ×××××××Ē ××××ר ׊××× ×ĸ×× ×××× ×ק××× ××Ē קר××ר×Ē ×××××ק ׊×××! ××ר׊×× ×××× ××ĸ×Š× ××Ē ××Ļ×ĸ× ××× ××ץ×ĸ ×קר×××¨× ×Š××× ××ĸ×ר×Ē ×קץפ××× ×.